rs52822694

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_181078.3(IL21R):​c.824G>A​(p.Arg275Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00974 in 1,613,584 control chromosomes in the GnomAD database, including 106 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0067 ( 7 hom., cov: 32)
Exomes 𝑓: 0.010 ( 99 hom. )

Consequence

IL21R
NM_181078.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: -0.817
Variant links:
Genes affected
IL21R (HGNC:6006): (interleukin 21 receptor) The protein encoded by this gene is a cytokine receptor for interleukin 21 (IL21). It belongs to the type I cytokine receptors, and has been shown to form a heterodimeric receptor complex with the common gamma-chain, a receptor subunit also shared by the receptors for interleukin 2, 4, 7, 9, and 15. This receptor transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells. The ligand binding of this receptor leads to the activation of multiple downstream signaling molecules, including JAK1, JAK3, STAT1, and STAT3. Knockout studies of a similar gene in mouse suggest a role for this gene in regulating immunoglobulin production. Three alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005239427).
BP6
Variant 16-27446045-G-A is Benign according to our data. Variant chr16-27446045-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 252799.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=2, Uncertain_significance=2}.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IL21RNM_181078.3 linkuse as main transcriptc.824G>A p.Arg275Gln missense_variant 8/9 ENST00000337929.8 NP_851564.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IL21RENST00000337929.8 linkuse as main transcriptc.824G>A p.Arg275Gln missense_variant 8/91 NM_181078.3 ENSP00000338010 P1

Frequencies

GnomAD3 genomes
AF:
0.00672
AC:
1021
AN:
152040
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00511
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0118
Gnomad OTH
AF:
0.00718
GnomAD3 exomes
AF:
0.00560
AC:
1404
AN:
250642
Hom.:
8
AF XY:
0.00551
AC XY:
747
AN XY:
135496
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.00451
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00115
Gnomad FIN exome
AF:
0.00301
Gnomad NFE exome
AF:
0.00954
Gnomad OTH exome
AF:
0.00739
GnomAD4 exome
AF:
0.0101
AC:
14702
AN:
1461426
Hom.:
99
Cov.:
31
AF XY:
0.00986
AC XY:
7165
AN XY:
727024
show subpopulations
Gnomad4 AFR exome
AF:
0.00149
Gnomad4 AMR exome
AF:
0.00459
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00128
Gnomad4 FIN exome
AF:
0.00307
Gnomad4 NFE exome
AF:
0.0122
Gnomad4 OTH exome
AF:
0.00901
GnomAD4 genome
AF:
0.00671
AC:
1021
AN:
152158
Hom.:
7
Cov.:
32
AF XY:
0.00629
AC XY:
468
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.00222
Gnomad4 AMR
AF:
0.00510
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000623
Gnomad4 FIN
AF:
0.00255
Gnomad4 NFE
AF:
0.0118
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00852
Hom.:
14
Bravo
AF:
0.00663
TwinsUK
AF:
0.0116
AC:
43
ALSPAC
AF:
0.0153
AC:
59
ESP6500AA
AF:
0.00319
AC:
14
ESP6500EA
AF:
0.0116
AC:
100
ExAC
AF:
0.00528
AC:
641
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.0103

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024IL21R: BP4, BS1, BS2 -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaNov 24, 2015- -
IgE responsiveness, atopic;C3554687:Cryptosporidiosis-chronic cholangitis-liver disease syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021IL21R NM_021798.3 exon 8 p.Arg275Gln (c.824G>A): This variant has not been reported in the literature but is present in 0.9% (1254/128760) of European alleles, including 9 homozygotes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/16-27457366-G-A). This variant is present in ClinVar (Variation ID: 252799). This variant amino acid Glutamine (Gln) is present in >10 species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Cryptosporidiosis-chronic cholangitis-liver disease syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 16, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.41
DANN
Benign
0.87
DEOGEN2
Benign
0.058
T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.21
.;.;T
MetaRNN
Benign
0.0052
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L;L;L
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.20
T
PROVEAN
Benign
0.55
N;N;N
REVEL
Benign
0.0070
Sift
Benign
0.61
T;T;T
Sift4G
Benign
0.41
T;T;T
Polyphen
0.026
B;B;B
Vest4
0.14
MVP
0.47
MPC
0.32
ClinPred
0.0018
T
GERP RS
-8.8
Varity_R
0.033
gMVP
0.053

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs52822694; hg19: chr16-27457366; COSMIC: COSV61972191; COSMIC: COSV61972191; API